Haleon plc (NYSE:HLN) Receives $10.95 Consensus Price Target from Brokerages

Haleon plc (NYSE:HLN) has received a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $10.95.

A number of equities analysts recently weighed in on HLN shares. Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday. Sanford C. Bernstein cut shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Finally, UBS Group raised shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st.

Hedge Funds Weigh In On Haleon

A number of hedge funds have recently bought and sold shares of HLN. Fortitude Family Office LLC bought a new position in Haleon during the third quarter worth $28,000. Versant Capital Management Inc raised its stake in Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after buying an additional 3,348 shares during the last quarter. Toronto Dominion Bank raised its stake in Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after buying an additional 3,470 shares during the last quarter. Prospera Private Wealth LLC bought a new position in Haleon during the third quarter worth $57,000. Finally, BOKF NA raised its stake in Haleon by 68.8% during the second quarter. BOKF NA now owns 6,972 shares of the company’s stock worth $58,000 after buying an additional 2,842 shares during the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

HLN stock opened at $9.10 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The company has a 50 day moving average price of $9.59 and a 200 day moving average price of $9.69. Haleon has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The stock has a market capitalization of $41.19 billion, a PE ratio of 26.76, a price-to-earnings-growth ratio of 2.95 and a beta of 0.29.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.